An efficient vaccine against bovine leukemia virus

17th International Conference on Human Retroviruses: HTLV and Related Viruses, Trois Ilets, Martinique,(FWI). 18-21 June 2015

Detalles Bibliográficos
Autores principales: Gutierrez, Gerónimo, Rodríguez, Sabrina M., Vilor, Agustín, Gillet, Nicolas A., DeBrogniez, Alix, Trono, Karina Gabriela, Willems, Luc
Formato: info:ar-repo/semantics/artículo
Lenguaje:Inglés
Publicado: BioMed Central 2019
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/4477
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578685/
_version_ 1855035330532474880
author Gutierrez, Gerónimo
Rodríguez, Sabrina M.
Vilor, Agustín
Gillet, Nicolas A.
DeBrogniez, Alix
Trono, Karina Gabriela
Willems, Luc
author_browse DeBrogniez, Alix
Gillet, Nicolas A.
Gutierrez, Gerónimo
Rodríguez, Sabrina M.
Trono, Karina Gabriela
Vilor, Agustín
Willems, Luc
author_facet Gutierrez, Gerónimo
Rodríguez, Sabrina M.
Vilor, Agustín
Gillet, Nicolas A.
DeBrogniez, Alix
Trono, Karina Gabriela
Willems, Luc
author_sort Gutierrez, Gerónimo
collection INTA Digital
description 17th International Conference on Human Retroviruses: HTLV and Related Viruses, Trois Ilets, Martinique,(FWI). 18-21 June 2015
format info:ar-repo/semantics/artículo
id INTA4477
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2019
publishDateRange 2019
publishDateSort 2019
publisher BioMed Central
publisherStr BioMed Central
record_format dspace
spelling INTA44772019-02-21T14:34:54Z An efficient vaccine against bovine leukemia virus Gutierrez, Gerónimo Rodríguez, Sabrina M. Vilor, Agustín Gillet, Nicolas A. DeBrogniez, Alix Trono, Karina Gabriela Willems, Luc Leucemia Leukaemia Virus Leucemia Bovina Bovine Leukaemia Virus Vacuna Vaccines 17th International Conference on Human Retroviruses: HTLV and Related Viruses, Trois Ilets, Martinique,(FWI). 18-21 June 2015 Previous attempts to produce a vaccine against BLV faced problems of efficacy (i.e. only a fraction of animals were protected), persistence (i.e. rapid decrease of immune protection), cost (e.g. production of purified proteins) or safety (e.g. genetically modified hybrid viruses). We have designed a novel strategy based on the use of a live-attenuated BLV provirus. The rationale behind this strategy relies on the deletion of genes required to induce pathogenesis maintaining integrity of those involved in infectivity. We have identified a BLV deleted provirus that is infectious in cattle but replicates at reduced levels in cows as shown by real-time quantitative PCR. The deletant elicits a strong anti-BLV immune response as indicated by wild-type antibody titers. Vaccinated animals but not uninfected controls resist challenge by a wild type BLV virus. The deletant does not spread to uninfected sentinels maintained during 5 years in the same herd supporting biosafety of the vaccine. Passive immunity, but not viral infection, is transmitted to the newborn calves via the maternal colostrum. Assays regarding production, storage and delivery of the vaccine, as well as safety of the milk produced by vaccinated cows are currently being carried out with the aim to start a large scale trial that will be held in Argentina in real dairy conditions during this year. Instituto de Virología Fil: Gutierrez, Gerónimo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Rodríguez, Sabrina M. University of Liège. Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics; Belgica Fil: Vilor, Agustín. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Gillet, Nicolas A. University of Liège. Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics; Belgica. University of Liège. Molecular and Cellular Biology, Gembloux Agro-Bio Tech; Belgica Fil: DeBrogniez, Alix. University of Liège. Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics; Belgica. University of Liège. Molecular and Cellular Biology, Gembloux Agro-Bio Tech; Belgica Fil: Trono, Karina Gabriela. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Willems, Luc. University of Liège. Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics; Belgica. University of Liège. Molecular and Cellular Biology, Gembloux Agro-Bio Tech; Belgica 2019-02-20T18:14:10Z 2019-02-20T18:14:10Z 2015 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/4477 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578685/ 1742-4690 10.1186/1742-4690-12-S1-I1 eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf BioMed Central Retrovirology 12 (Suppl 1) : P3. (2015)
spellingShingle Leucemia
Leukaemia
Virus Leucemia Bovina
Bovine Leukaemia Virus
Vacuna
Vaccines
Gutierrez, Gerónimo
Rodríguez, Sabrina M.
Vilor, Agustín
Gillet, Nicolas A.
DeBrogniez, Alix
Trono, Karina Gabriela
Willems, Luc
An efficient vaccine against bovine leukemia virus
title An efficient vaccine against bovine leukemia virus
title_full An efficient vaccine against bovine leukemia virus
title_fullStr An efficient vaccine against bovine leukemia virus
title_full_unstemmed An efficient vaccine against bovine leukemia virus
title_short An efficient vaccine against bovine leukemia virus
title_sort efficient vaccine against bovine leukemia virus
topic Leucemia
Leukaemia
Virus Leucemia Bovina
Bovine Leukaemia Virus
Vacuna
Vaccines
url http://hdl.handle.net/20.500.12123/4477
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578685/
work_keys_str_mv AT gutierrezgeronimo anefficientvaccineagainstbovineleukemiavirus
AT rodriguezsabrinam anefficientvaccineagainstbovineleukemiavirus
AT viloragustin anefficientvaccineagainstbovineleukemiavirus
AT gilletnicolasa anefficientvaccineagainstbovineleukemiavirus
AT debrogniezalix anefficientvaccineagainstbovineleukemiavirus
AT tronokarinagabriela anefficientvaccineagainstbovineleukemiavirus
AT willemsluc anefficientvaccineagainstbovineleukemiavirus
AT gutierrezgeronimo efficientvaccineagainstbovineleukemiavirus
AT rodriguezsabrinam efficientvaccineagainstbovineleukemiavirus
AT viloragustin efficientvaccineagainstbovineleukemiavirus
AT gilletnicolasa efficientvaccineagainstbovineleukemiavirus
AT debrogniezalix efficientvaccineagainstbovineleukemiavirus
AT tronokarinagabriela efficientvaccineagainstbovineleukemiavirus
AT willemsluc efficientvaccineagainstbovineleukemiavirus